Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature

Gastrointestinal stromal tumor is a rare mesenchymal tumor. Sorafenib is an effective medication in these tumors based on two phase II clinical trials and a retrospective analysis. We report a rare case of a 57-year-old male with acute hepatotoxicity from sorafenib. He was treated conservatively wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Murad, Waheed, Rabinowitz, Ian, Lee, Fa-Chyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435291/
https://www.ncbi.nlm.nih.gov/pubmed/26157843
http://dx.doi.org/10.14309/crj.2014.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435291/
https://www.ncbi.nlm.nih.gov/pubmed/26157843
http://dx.doi.org/10.14309/crj.2014.19

Ejemplares similares